Medicines Patent Pool
About
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries (LMICs). Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. MPP’s mandate covers patented medicines for infectious diseases – HIV, TB, hepatitis C and also non-communicable diseases including cancer, cardiovascular diseases and diabetes, in addition to COVID-19 treatments and technologies.
MPP operates as a non-profit voluntary licensing mechanism through partnerships with originator pharmaceutical companies and generic manufacturers that facilitate access and promote innovation. The terms and conditions in MPP licences seek to improve treatment options for the broadest number of people living in LMICs and are negotiated on a case-by-case basis with each patent holder.
Positively impacting peoples’ lives is one of the main goals of MPP activities. MPP’s impact assessment is based on country-level modelling and contrasting MPP’s contribution to alternative scenarios where key WHO-recommended medicines would not have been available through MPP licences. For further information regarding our work, please visit our website
